Visual outcomes at 3 and 6-month time intervals after treatment
| FLEK (n=66) | PKP (n=71) | p Value | |
| 3 Months | |||
| Logmar UCVA (SD) | 0.91 (0.55) | 0.94 (0.37) | 0.42 |
| Logmar BSCVA (SD) | 0.46 (0.40) | 0.69 (0.38) | 0.001 |
| MRSE (SD) | −2.79 (5.66) | −0.64 (5.66) | 0.05 |
| TA (SD) | 5.09 (3.55) | 7.33 (4.61) | 0.001 |
| FLEK (n=54) | PKP (n=71) | p Value | |
| 6 Months | |||
| LogMar UCVA (SD) | 0.91 (0.69) | 1.00 (0.70) | 0.35 |
| LogMar BSCVA (SD) | 0.44 (0.49) | 0.57 (0.58) | 0.12 |
| MRSE (SD) | −3.76 (4.63) | −3.31 (5.51) | 0.52 |
| TA (SD) | 4.76 (3.41) | 5.91 (4.53) | 0.15 |
BSCVA, best spectacle-corrected visual acuity; FLEK, femtosecond laser-enabled keratoplasty; PKP, penetrating keratoplasty; TA, topographically determined astigmatism; UCVA, uncorrected visual acuity.